Insulet
PODD
#1001
Rank
NZ$34.13 B
Marketcap
$486.63
Share price
-0.10%
Change (1 day)
44.51%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.81

According to Insulet's latest financial reports the company's current EPS (TTM) is $3.03. In 2022 the company made an earnings per share (EPS) of $0.12 a decrease over its 2021 EPS that were of $0.41.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.812177.79%
2022$0.12-69.57%
2021$0.41109.09%
2020$0.19-38.89%
2019$0.32200%
2018$0.11-113.04%
2017-$0.81-9.8%
2016-$0.90-60.77%
2015-$2.2939.78%
2014-$1.6412.05%
2013-$1.46-23.15%
2012-$1.9110.2%
2011-$1.73-36.36%
2010-$2.72-36.63%
2009-$4.29-29.36%
2008-$6.07-86.74%
2007-$45.78-64.04%
2006-$127.30122.23%
2005-$57.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.56-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.70-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.73-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.85 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.24 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.80 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$9.58 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA